Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 3
2003 8
2004 2
2005 7
2006 13
2007 15
2008 11
2009 12
2010 13
2011 7
2012 9
2013 9
2014 9
2015 23
2016 13
2017 5
2018 13
2019 11
2020 11
2021 17
2022 17
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
The Costs of Anonymization: Case Study Using Clinical Data.
Pilgram L, Meurers T, Malin B, Schaeffner E, Eckardt KU, Prasser F; GCKD Investigators. Pilgram L, et al. J Med Internet Res. 2024 Apr 24;26:e49445. doi: 10.2196/49445. J Med Internet Res. 2024. PMID: 38657232 Free article.
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD.
Sommerer C, Müller-Krebs S, Nadal J, Schultheiss UT, Friedrich N, Nauck M, Schmid M, Nußhag C, Reiser J, Eckardt KU, Zeier M, Hayek SS; German Chronic Kidney Disease Investigators. Sommerer C, et al. Kidney Int Rep. 2023 Sep 9;8(11):2265-2275. doi: 10.1016/j.ekir.2023.08.038. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025216 Free PMC article.
Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.
Schneider MP, Schmid M, Nadal J, Krane V, Saritas T, Busch M, Schultheiss UT, Meiselbach H, Friedrich N, Nauck M, Floege J, Kronenberg F, Wanner C, Eckardt KU; GCKD study investigators. Schneider MP, et al. Kidney Med. 2023 Sep 17;5(11):100725. doi: 10.1016/j.xkme.2023.100725. eCollection 2023 Nov. Kidney Med. 2023. PMID: 37915964 Free PMC article.
Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort.
Reimer KC, Nadal J, Meiselbach H, Schmid M, Schultheiss UT, Kotsis F, Stockmann H, Friedrich N, Nauck M, Krane V, Eckardt KU, Schneider MP, Kramann R, Floege J, Saritas T; GCKD study investigators. Reimer KC, et al. Bone Res. 2023 Oct 20;11(1):52. doi: 10.1038/s41413-023-00291-8. Bone Res. 2023. PMID: 37857629 Free PMC article.
Inversin (NPHP2) and Vangl2 are required for normal zebrafish cloaca formation.
Wang H, Zaiser F, Eckert P, Ruf J, Kayser N, Veenstra AC, Müller M, Haas R, Walz G, Yakulov TA. Wang H, et al. Among authors: walz g. Biochem Biophys Res Commun. 2023 Sep 17;673:9-15. doi: 10.1016/j.bbrc.2023.06.058. Epub 2023 Jun 19. Biochem Biophys Res Commun. 2023. PMID: 37352572
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease.
Cejka V, Störk S, Nadal J, Schmid M, Sommerer C, Sitter T, Meiselbach H, Busch M, Schneider MP, Saritas T, Schultheiss UT, Kotsis F, Wanner C, Eckardt KU, Krane V; GCKD Study Investigators. Cejka V, et al. J Ren Nutr. 2023 Jul;33(4):546-554. doi: 10.1053/j.jrn.2023.04.006. Epub 2023 Apr 27. J Ren Nutr. 2023. PMID: 37116626 Free article.
220 results